MedTrace Logo

Complete Blood Count-derived Indexes in Inflammatory Modic Changes

NCT06440096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2024-06-03

No results posted yet for this study

Summary

Some indicators generated from hemogram such as neutrophil/lymphocyte (NLR) have been suggested as biomarkers of systemic inflammation. Type I Modic changes (MCs) have inflammatory nature histologically and are more painful clinically than type II MCs. Therefore, we hypothesized that patients with type I MCs may have increased inflammatory biomarkers and low back pain than those with type II MCs. The aim of this study was to test this hypothesis.

Conditions

  • Modic Changes

Interventions

DIAGNOSTIC_TEST

hemogram

hemogram

Sponsors & Collaborators

  • Veysel Delen, MD

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-30
Primary Completion
2024-01-05
Completion
2024-01-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06440096 on ClinicalTrials.gov